U.S. federal trademark · Serial No. 79416326 · Reg. No. 8026660
Medicines for human purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; pharmaceutical preparations for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; drugs for medical purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; biological preparations for use in cell cultures for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; adjuvants for medical purposes; injectable solutions for medical purposes, namely, hyaluronidase in injectable form; aqueous solutions for medical purposes containing recombinant human hyaluronidase for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; biochemical drugs for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.